Gastrointestinal Cancer News

Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with standard of care for patients with locally advanced pancreatic cancer, according to results of the phase 3 TiGeR-PaC study.

The 2018 introduction of calorie labels to restaurant menus appears to have yielded a net reduction in caloric intake of 20 to 60 calories per meal among Americans, potentially reducing risk for obesity-associated cancers.

One-fifth of patients who underwent gallbladder cancer surgery at top-performing centers experienced related complications within 90 days, according to results of a retrospective study published in Annals of Surgical Oncology.

Cardiorespiratory fitness levels appeared associated with cancer risk and mortality among a cohort of Swedish men, according to study results published in JAMA Network Open.

The rising incidence of colorectal cancer among young adult patients is disturbing but not surprising.

The FDA announced several regulatory actions the past few weeks.

An analysis of data from 2013 to 2022 showed that only 34% of people diagnosed with hepatitis C in the United States were cured or cleared of the virus, with many still lacking access to highly effective treatments.

Survivors of cancer in adolescence and young adulthood face increased risk for subsequent HPV-related cancer diagnoses, according to research conducted at University of Utah’s Huntsman Cancer Institute.

A nurse-led cancer genetics program embedded within an oncology clinic appeared associated with a significant increase in genetic testing rates vs. a telegenetics service among Black veterans, according to a study in JCO Oncology Practice.

Scoring systems based on behavioral and clinical data outperformed existing scores in predicting risk for hepatocellular carcinoma in patients with chronic hepatitis B virus infection, according to data presented at the EASL Congress.